Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral dclonine mucilage for prevention of postoperative sore throat after general anesthesia
ChiCTR2300074345Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of University of Science and Technology of China
- Start
- Aug 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of dyclonine in Post-extubation sore throat (POST) (4 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: VAS score of postoperative sore throat and Prince-Henry pharyngeal pain grade. Started Aug 2023; status: recruiting.
02
Drugs
dyclonine
03
Conditions
Post-extubation sore throat (POST)
Beyond the preview
Go deeper on ChiCTR2300074345.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074345.